CALT - Asahi Kasei Makes $1.1B Offer For Swedish Drugmaker Calliditas Therapeutics Enhancing Pharma Growth Strategy | Benzinga
Japanese chemical company Asahi Kasei Corporation made a $1.1 billion (SEK 11.164 billion) takeover bid for Swedish pharmaceutical company Calliditas Therapeutics AB (NASDAQ:CALT).
The deal offers 208 Swedish krona in cash per share and a concurrent offer for American Depositary Shares, each representing two Shares in Calliditas, for 416 Swedish krona in cash per ADS.
The Calliditas board unanimously recommended that shareholders accept the deal.
Asahi Kasei, especially the pharmaceutical business, aims to expand globally by specializing in immunology, transplantation, and adjacent diseases.
Asahi Kasei continues to focus on ...